Skip to main content
The Journal of Clinical Hypertension logoLink to The Journal of Clinical Hypertension
. 2025 Feb 7;27(2):e70010. doi: 10.1111/jch.70010

High Heart Rate and Hypertension: Two Intertwined Cardiovascular Risk Factors

Paolo Palatini 1,
PMCID: PMC11804763  PMID: 39918710

1.

A large number of studies have shown that high heart rate (HR) is correlated with many risk factors for atherosclerosis and cardiovascular events, including high blood pressure, dyslipidemia, hyperinsulinemia, hyperglycemia, and obesity [1, 2, 3]. These associations have been observed in general populations as well as in patients with hypertension, diabetes, coronary artery disease, and heart failure, indicating that measurement of HR should be an important component of cardiovascular risk assessment. Although many prospective studies performed in general populations showed significant associations between the baseline office HR and subsequent blood pressure or hypertension, in only a few studies did the predictive power of HR remain significant after controlling for the baseline blood pressure level [4, 5]. Furthermore, the confounding effect of physical fitness was considered only in the CARDIA study [6] in the United States, in people aged 18 to 30 years. These results were later confirmed by the Kailuan prospective study [7], which included a large number of participants aged 38 to 54 years, and by a prospective cohort study carried out in rural China in 39‐ to 59‐year‐old subjects [8]. Finally, in a meta‐analysis of 9 cohort studies encompassing 79 399 individuals, Shen et al. found a linear dose–response association between HR and incident hypertension in adults [9]. All these studies were carried out in young or middle‐aged people while little information was available for older individuals.

This knowledge gap was addressed by Lou and colleagues in an article published in this issue of Journal of Clinical Hypertension [10]. These investigators showed that high HR was associated with an increased risk of developing hypertension also in older individuals, with a 6% increase in risk for every 10 beats/min increment in HR. This association may explain at least in part the higher risk of mortality found in elderly subjects with fast HR [11].

As hypothesized by Lou and colleagues, a heightened sympathetic activity may explain why subjects with high HR tend to develop sustained hypertension in later years [10]. A high sympathetic activity causes an increase in cardiac output, peripheral vascular resistance, and sodium reabsorption in the kidney, which leads to an

Elevation of blood pressure [12]. However, whether tachycardia in these individuals reflects a temporary reaction to the medical environment or is the consequence of a stable sympathetic activation is still a matter of debate. Results of the HARVEST Study showed that in most subjects with elevated HR at the initial visit, HR tends to return to normal values after baseline assessment, and that these subjects are not at increased risk of future hypertension [5]. This suggests that a transient increase in sympathetic activity on a background of normal autonomic nervous system tone does not seem to have a detrimental effect and that only a sustained elevation of the sympathetic tone can affect future blood pressure levels. Whether HR has a direct effect on the arterial wall or is only a marker of autonomic nervous system dysfunction is still an unresolved issue.

Another interesting finding of Lou and colleagues study is that the longitudinal association between baseline HR and future hypertension was present in the sedentary subjects, with a hazard ratio of 1.09 (95% CI, 1.02–1.17), but not in the participants performing regular physical activity (1.02; 0.94–1.11) [10]. The favorable effect of exercise for the prevention or treatment of hypertension has been well documented [13]. In addition, physical activity has a beneficial effect also on lipids and other metabolic factors [13], and on the hemodynamic responsiveness to stressors by attenuating or even abolishing the detrimental effects of these risk factors [14]. In the HARVEST study, we showed that the risk of hypertension associated with high uric acid was present only among the sedentary participants and not among those engaging in endurance sports [15].

A reduction of blood pressure responsiveness to stressors has been described in physically active individuals [16]. In the HARVEST, people who performed regular physical activity had a blunted blood pressure response to public speaking, a powerful psychological stressor, and a lower risk of future hypertension compared to subjects with sedentary habits [14]. As mentioned above, high HR is often a marker of increased sympathetic activity. Physical activity has a favorable action on the sympathovagal balance, which can result in decreased cardiac–sympathetic drive, in part by enhancing baroreceptor sensitivity [17]. In addition, exercise decreases the activity of the renin–angiotensin system [18]. These mechanisms may account for the beneficial effect of exercise training on blood pressure, which may have contributed to the prevention of hypertension in Lou and colleagues active participants. Central autonomic adaptations in response to regular physical activity would be responsible for the reduced blood pressure responsiveness to stressors [17] and might represent an additional mechanistic pathway for the decreased tendency to develop hypertension in physically active individuals [19]. Overall, these findings suggest that regular exercise may counteract many pathophysiological mechanisms involved in the development of hypertension.

A limitation of Lou and colleagues study is that HR was measured only at baseline, and thus information on HR during the follow‐up was not available. HR changes during the first months or years of follow‐up may add important prognostic information to that provided by the baseline HR because they allow to distinguish people with transiently elevated HR from those with sustained tachycardia [20]. In the HARVEST study, the participants with high HR throughout the follow‐up had a doubled risk of developing hypertension compared with those with a high HR only at the initial visit, in whom the HR elevation was probably caused by a marked alarm reaction that attenuated during subsequent visits [5].

The results of Lou and colleagues study have implications for the management of elderly people with elevated HR. Up to now, no human study has demonstrated the efficacy and the risk–benefit ratio of cardiac slowing drugs in patients without cardiac diseases. Pharmacological treatment of high HR in noncardiac subjects thus appears at the very least to be premature. The pathogenetic considerations discussed above suggest that in people with tachycardia, rather than merely reduce the elevated HR, it would be rationale to use a treatment that also corrects the underlying pathogenetic mechanism, restoring a normal sympathovagal balance. One such goal can be achieved with the improvement of an unhealthy lifestyle. Besides reducing the consumption of tobacco, alcohol, and caffeinated beverages, a program of regular physical activity should be implemented. Exercise causes a reduction of HR by decreasing sympathetic activity and increasing vagal tone. Regular endurance exercise has not only a beneficial effect on HR but also a favorable impact on all factors of the insulin resistance syndrome: overweight, serum insulin, blood pressure, and plasma lipids [13].

Author Contributions

Paolo Palatini is the sole author of this article and took care of implementing and writing the article.

Conflicts of Interest

The author declares no conflicts of interest.

References

  • 1. Palatini P. and Julius S., “Review Article: Heart Rate and the Cardiovascular Risk,” Journal of Hypertension 15 (1997): 3–17. [DOI] [PubMed] [Google Scholar]
  • 2. Shigetoh Y., Adachi H., Yamagishi S., et al., “Higher Heart Rate May Predispose to Obesity and Diabetes Mellitus: 20‐Year Prospective Study in a General Population,” American Journal of Hypertension 22 (2009): 151–155. [DOI] [PubMed] [Google Scholar]
  • 3. Wu X., Du R., Hu C., et al., “Resting Heart Rate Is Associated With Metabolic Syndrome and Predicted 10‐Year Risk of Cardiovascular Disease: A Cross‐sectional Study,” Journal of Diabetes 11 (2019): 884–894. [DOI] [PubMed] [Google Scholar]
  • 4. Kim J. R., Kiefe C. I., Liu K., Williams O. D., Jacobs D. R. Jr, and Oberman A., “Heart Rate and Subsequent Blood Pressure in Young Adults. The CARDIA Study,” Hypertension 33 (1999): 640–646. [DOI] [PubMed] [Google Scholar]
  • 5. Palatini P., Dorigatti F., Zaetta V., et al., “Heart Rate as a Predictor of Development of Sustained Hypertension in Subjects Screened for Stage 1 Hypertension: The HARVEST Study,” Journal of Hypertension 24 (2006): 1873–1880. [DOI] [PubMed] [Google Scholar]
  • 6. Colangelo L. A., Yano Y., Jacobs D. R. Jr, and Lloyd‐Jones D. M., “Association of Resting Heart Rate with Blood Pressure and Incident Hypertension over 30 Years in Black and White Adults: The CARDIA Study,” Hypertension 76 (2020): 692–698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Wang A., Liu X., Guo X., et al., “Resting Heart Rate and Risk of Hypertension: Results of the Kailuan Cohort Study,” Journal of Hypertension 32 (2014): 1600–1605. Discussion 1605. [DOI] [PubMed] [Google Scholar]
  • 8. Zhao Y., Qin P., Sun H., et al., “Resting Heart Rate and Its Dynamic Change and the Risk of Hypertension: The Rural Chinese Cohort Study,” Journal of Human Hypertension 34 (2020): 528–535. [DOI] [PubMed] [Google Scholar]
  • 9. Shen L., Wang Y., Jiang X., Ren Y., Han C., and Yang Y., “Dose‐Response Association of Resting Heart Rate and Hypertension in Adults: A Systematic Review and Meta‐Analysis of Cohort Studies,” Medicine 99 (2020): e19401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Lou S., Yu Z., Song Y., and Liu D., “Association Between Resting Heart Rate and the Risk of Incident Hypertension Among Older Chinese Adults: A Prospective Cohort Study,” Journal of Clinical Hypertension 27 (2025): e14973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Palatini P., Casiglia E., Julius S., and Pessina A. C., “High Heart Rate: A Risk Factor for Cardiovascular Death in Elderly Men,” Archives of Internal Medicine 159, no. 6 (1999): 585–592. [DOI] [PubMed] [Google Scholar]
  • 12. Palatini P. and Julius S., “The Physiological Determinants and Risk Correlations of Elevated Heart Rate,” American Journal of Hypertension 12 (1999): 3S–8S. [PubMed] [Google Scholar]
  • 13. Cornelissen V. A. and Fagard R. H., “Effects of Endurance Training on Blood Pressure, Blood Pressure‐Regulating Mechanisms, and Cardiovascular Risk Factors,” Hypertension 46 (2005): 667–675. [DOI] [PubMed] [Google Scholar]
  • 14. Palatini P., Bratti P., Palomba D., et al., “Regular Physical Activity Attenuates the BP Response to Public Speaking and Delays the Development of Hypertension,” Journal of Hypertension 28 (2010): 1186–1193. [PubMed] [Google Scholar]
  • 15. Saladini F., Mos L., Fania C., Garavelli G., Casiglia E., and Palatini P., “Regular Physical Activity Prevents Development of Hypertension in Young People With Hyperuricemia,” Journal of Hypertension 35, no. 5 (2017): 994–1001. [DOI] [PubMed] [Google Scholar]
  • 16. Crews D. J. and Landers D. M., “A Meta‐analytic Review of Aerobic Fitness and Reactivity to Psychosocial Stressors,” Medicine & Science in Sports & Exercise 19 (1987): S114–S120. [PubMed] [Google Scholar]
  • 17. Guzzetti S., Piccaluga E., Casati R., et al., “Sympathetic Predominance in Essential Hypertension: A Study Employing Spectral Analysis of Heart Rate Variability,” Journal of Hypertension 6 (1988): 711–717. [DOI] [PubMed] [Google Scholar]
  • 18. Palatini P., Canali C., Graniero G. R., et al., “Relationship of Plasma Renin Activity With Caffeine Intake and Physical Training in Mild Hypertensive Men. HARVEST Study Group,” European Journal of Epidemiology 12 (1996): 485–491. [DOI] [PubMed] [Google Scholar]
  • 19. Laterza M. C., de Matos L. D., Trombetta I. C., et al., “Exercise Training Restores Baroreflex Sensitivity in Never‐Treated Hypertensive Patients,” Hypertension 49 (2007): 1298–1306. [DOI] [PubMed] [Google Scholar]
  • 20. Nauman J., Janszky I., Vatten L. J., and Wisløff U., “Temporal Changes in Resting Heart Rate and Deaths From Ischemic Heart Disease,” JAMA 306 (2011): 2579–2587. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Clinical Hypertension are provided here courtesy of Wiley

RESOURCES